Clarus Lifesciences I L.P. 13D/13G Filings for Sientra, Inc. (SIEN)

Clarus Lifesciences I L.P. 13D and 13G filings for Sientra, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-05-04
5:18 pm
Unchanged
2022-05-0413DSientra, Inc.
SIEN
Clarus Lifesciences I L.P.273,077
4.400%
0
(Unchanged)
Filing